Aegon Ltd.
Aegon Ltd. Q3 FY25 Results — Earnings Call Analysis
Q3 FY25 earnings call: what management said on revenue, margins and capex.
Top 4 Insurance companies on management guidance
See the sector's top 10 — free with your mobile number.
What the Q3 FY25 call signalled
2 of 4 strong
The short version
- Americas: Continued growth in strategic assets at Transamerica; 14% increase in licensed agents at World Financial Group contributing to higher productivity and 13% increase in new life sales in Individual Life business. - Operating result increased by 19% year-on-year in H1 2025, reaching EUR 845 million, driven mainly by profitable business growth and less unfavorable claims experience in the U.S., U.K., and International segments.
From Aegon Ltd.'s Q3 FY25 earnings-call transcript · updated 29 May 2026.
Revenue & Sales Performance
- Americas: Continued growth in strategic assets at Transamerica; 14% increase in licensed agents at World Financial Group contributing to higher productivity and 13% increase in new life sales in Individual Life business.
- Brokerage channel: Strong new life sales driven by launch of fully digital whole life final expense product.
- RILA product: Net deposits nearly doubled compared with last year, indicating strong growth.
- Savings and investments segment: Solid net deposits in retirement plans, driven by midsized and large pooled plans; growth in general accounts stable value products and IRAs to diversify revenue streams.
- U.K.: Progress on strategy with onboarding of larger workplace schemes, though adviser platform impacted by market consolidation.
- International segment: Higher new life sales in Brazil, China, Spain, and Portugal driven by joint ventures and partnerships.
2 more points from Aegon Ltd.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Aegon Ltd. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The focus is on ongoing operational investments, such as growth in strategic assets, higher new business strain (especially in U.S. strategic assets), and investments in business growth.
- Notable capital management activities include share buybacks totaling EUR 400 million in the second half of 2025 and a plan to reduce cash capital at holding to around EUR 1 billion by end of 2026.
- The company is executing variable annuity fee hedging to stabilize capital and earnings.
- A key upcoming strategic move under review is the potential relocation of Aegon's legal domicile and head office to the U.S. along with the implementation of U.S. GAAP reporting, expected to take 2 to 3 years.
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Aegon Ltd. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of the first half of 2025, Aegon reported strong commercial momentum with higher new life sales and net deposits across key markets (Page 2).
- In the U.S., noted as the largest market (~70% of business), there was growth in new life sales by 13% in the Individual Life business (Page 2).
- Retirement plans business showed solid net deposits, partly supported by onboarding a large pooled plan (approx. EUR 1.9 billion) (Pages 2 and 10).
- Workplace platform deposits in the U.K. saw lumpy but notable inflows due to the onboarding of larger schemes (Page 5).
2 more points from Aegon Ltd.'s call on order book
Create a free account to keep reading this call
Continue your research
Others in Insurance this season
- Prudential plc (Q3 FY25)
Prudential plc Q3 FY25 quarterly results analysis. Recruitment up over 40%, indicating strong agent growth and confidence in quality recruitment programs like P
Potential multibaggers · Q2 FY27
Potential multibaggers in Insurance
on management's own guidance
- Niva Bupa Health Insurance Company LtdGood growth2
- Max Financial Services LtdGood growth1
- Medi Assist Healthcare Services LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Aegon Ltd. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aegon Ltd. Q3 FY25 results?
- Americas: Continued growth in strategic assets at Transamerica; 14% increase in licensed agents at World Financial Group contributing to higher productivity and 13% increase in new life sales in Individual Life business. - Operating result increased by 19% year-on-year in H1 2025, reaching EUR 845 million, driven mainly by profitable business growth and less unfavorable claims experience in the U.S., U.K., and International segments.
What is Aegon Ltd. share price analysis?
Aegon Ltd. currently shows a below-average growth signal. The stock trades at a P/E of 12.5 with a market cap of $16,092. Investors should review the full earnings analysis for detailed insights.
Is Aegon Ltd. planning capital expenditure?
- The focus is on ongoing operational investments, such as growth in strategic assets, higher new business strain (especially in U.S.
Keep Aegon Ltd. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.